A Study of the Relative Bioavailability of ASC41 in Healthy Subjects
Clinical trial NCT04527250 · COMPLETED
Trial details
- NCT number
- NCT04527250
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2020-12-18
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.